ConvaTec Group PLC
OTC:CNVVY

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
OTC:CNVVY
Watchlist
Price: 12.64 USD -1.48% Market Closed
Market Cap: $6.5B

Operating Margin

20.3%
Current
Improving
by 3.2%
vs 3-y average of 17.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
20.3%
=
Operating Income
$354.9m
/
Revenue
$2.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
20.3%
=
Operating Income
$354.9m
/
Revenue
$2.4B

Peer Comparison

Country Company Market Cap Operating
Margin
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
JP
Hoya Corp
TSE:7741
8.7T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.9B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.6B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
8.6T KRW
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...

Market Distribution

Higher than 98% of companies in United Kingdom
Percentile
98th
Based on 3 579 companies
98th percentile
20.3%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

ConvaTec Group PLC
Glance View

Market Cap
6.5B USD
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CNVVY Intrinsic Value
15.76 USD
Undervaluation 20%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
20.3%
=
Operating Income
$354.9m
/
Revenue
$2.4B
What is ConvaTec Group PLC's current Operating Margin?

The current Operating Margin for ConvaTec Group PLC is 20.3%, which is above its 3-year median of 17.1%.

How has Operating Margin changed over time?

Over the last 3 years, ConvaTec Group PLC’s Operating Margin has increased from 9.9% to 20.3%. During this period, it reached a low of 9.9% on May 30, 2022 and a high of 20.7% on Jul 30, 2025.

Back to Top